Exagen Inc. to Participate in Fourth Quarter Investor Conferences

Rhea-AI Summary

Exagen (Nasdaq: XGN) said management will participate in two investor conferences in New York in November 2025: the 16th Annual Craig-Hallum Alpha Select Conference on November 18, 2025 at Sheraton New York Times Square, and the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum on November 20, 2025 at Westin NY Grand Central.

The appearances provide opportunities for investor updates and one‑on‑one meetings with company management.

CARLSBAD, Calif., Nov. 11, 2025 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing, today announced that management will participate in the following upcoming investor conferences:

16^th Annual Craig-Hallum Alpha Select Conference

Date: November 18, 2025

Location: Sheraton New York Times Square Hotel

Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum

Date: November 20, 2025

Location: Westin NY Grand Central - 212 E 42nd Street New York, NY 10017

About Exagen Inc.

Exagen Inc. (Nasdaq: XGN) is a leading provider of autoimmune diagnostics, committed to transforming care for patients with chronic and debilitating autoimmune conditions. Based in San Diego County, California, Exagen’s mission is to provide clarity in autoimmune disease decision-making and improve clinical outcomes through its innovative testing portfolio. The company’s flagship product, AVISE^® CTD, enables clinicians to more effectively diagnose complex autoimmune conditions such as lupus, rheumatoid arthritis, and Sjögren’s disease earlier and with greater accuracy. Exagen’s CLIA-certified, CAP-accredited laboratory specializes in the testing of rheumatic diseases, delivering precise and timely results, supported by a suite of AVISE-branded tests for disease diagnosis, prognosis, and monitoring. With a focus on research, innovation, education, and patient-centered care, Exagen is dedicated to addressing the ongoing challenges of autoimmune disease management.

For more information, visit Exagen.com or follow Exagen on LinkedIn.

Exagen Inc.
Ryan Douglas
IR@exagen.com
760.560.1525

FAQ

When will Exagen (XGN) present at the Craig-Hallum Alpha Select Conference?

Management will participate on November 18, 2025 at the Sheraton New York Times Square.

Where and when will Exagen (XGN) attend the Canaccord Genuity MedTech forum?

Exagen will attend on November 20, 2025 at the Westin NY Grand Central, 212 E 42nd Street, New York, NY.

Will Exagen (XGN) hold investor meetings during the November 2025 conferences?

The company said management will participate in the conferences, which typically include presentations and investor meetings.

How can investors access Exagen (XGN) presentations at the November 2025 events?

Investors should check conference agendas or Exagen investor relations for presentation timing and webcast availability.

Are the Exagen (XGN) conference appearances expected to include financial guidance or results?

The announcement lists conference participation only; any financial details would be disclosed separately by the company.

Who is the contact to arrange a one-on-one meeting with Exagen (XGN) at the conferences?

Investors should contact Exagen investor relations or the conference organizers to request one-on-one meetings.